secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scilex Holding Co (SCLX)
CIK:        0001820190
Form:       8-K
Filed at:   2025-01-03T23:59:59+00:00
Accession:  0001193125-25-000984
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Scilex defers $6.25M amortization payment, issues 5M shares to noteholders
--------------------------------------------------------------------------

- Entered deferral letters with Tranche B noteholders; first $6.25M amortization due Jan 2 deferred to Jan 31, then to Oct 8, 2026.
- Delivered 5M common shares to noteholders: Oramed 2.5M, BPY 720k, Nomis 1.28M, 3i LP 500k.
- Paid $1.11M toward amortization and make-whole interest to achieve further deferral to Oct 8, 2026.
- Term sheet provides for 4% royalty on worldwide net sales of Gloperba and Elyxyb (ex-Canada) for 10 years.
- Company seeking to extend Oramed promissory note maturity from March 21, 2025 to Dec 31, 2025; not yet agreed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1820190/000119312525000984/0001193125-25-000984-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1820190/000119312525000984/d894156d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-000984

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer